MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Hypothesis: The use of neurocytoprotectors helps restore the functional activity of mitochondria, improve the nervous activity of the retina and optic nerve, and stabilize the glaucomatous process.
Epistemonikos ID: 2da81191cdecfc610b446495c7ce88385fe3de70
First added on: Jun 01, 2024